1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by EPA/DHA (Omega 3) Ingredients Revenue
1.4 Market Analysis by Type
1.4.1 Global EPA/DHA (Omega 3) Ingredients Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Anchovy/Sardine
1.4.3 Cod Liver Oil
1.4.4 Salmon Oil
1.4.5 Algae Oil
1.4.6 High Concentrates
1.4.7 Medium Concentrates
1.4.8 Low Concentrates
1.5 Market by Application
1.5.1 Global EPA/DHA (Omega 3) Ingredients Market Share by Application: 2021-2026
1.5.2 Dietary Supplements
1.5.3 Functional Foods
1.5.4 Pharmaceuticals
1.5.5 Pet & Animal Feed
1.5.6 InfantFormulas
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global EPA/DHA (Omega 3) Ingredients Market
1.8.1 Global EPA/DHA (Omega 3) Ingredients Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global EPA/DHA (Omega 3) Ingredients Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global EPA/DHA (Omega 3) Ingredients Revenue Market Share by Manufacturers (2015-2020)
2.3 Global EPA/DHA (Omega 3) Ingredients Average Price by Manufacturers (2015-2020)
2.4 Manufacturers EPA/DHA (Omega 3) Ingredients Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global EPA/DHA (Omega 3) Ingredients Sales Volume Market Share by Region (2015-2020)
3.2 Global EPA/DHA (Omega 3) Ingredients Sales Revenue Market Share by Region (2015-2020)
3.3 North America EPA/DHA (Omega 3) Ingredients Sales Volume
3.3.1 North America EPA/DHA (Omega 3) Ingredients Sales Volume Growth Rate (2015-2020)
3.3.2 North America EPA/DHA (Omega 3) Ingredients Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia EPA/DHA (Omega 3) Ingredients Sales Volume
3.4.1 East Asia EPA/DHA (Omega 3) Ingredients Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia EPA/DHA (Omega 3) Ingredients Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe EPA/DHA (Omega 3) Ingredients Sales Volume (2015-2020)
3.5.1 Europe EPA/DHA (Omega 3) Ingredients Sales Volume Growth Rate (2015-2020)
3.5.2 Europe EPA/DHA (Omega 3) Ingredients Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia EPA/DHA (Omega 3) Ingredients Sales Volume (2015-2020)
3.6.1 South Asia EPA/DHA (Omega 3) Ingredients Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia EPA/DHA (Omega 3) Ingredients Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia EPA/DHA (Omega 3) Ingredients Sales Volume (2015-2020)
3.7.1 Southeast Asia EPA/DHA (Omega 3) Ingredients Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia EPA/DHA (Omega 3) Ingredients Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East EPA/DHA (Omega 3) Ingredients Sales Volume (2015-2020)
3.8.1 Middle East EPA/DHA (Omega 3) Ingredients Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East EPA/DHA (Omega 3) Ingredients Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa EPA/DHA (Omega 3) Ingredients Sales Volume (2015-2020)
3.9.1 Africa EPA/DHA (Omega 3) Ingredients Sales Volume Growth Rate (2015-2020)
3.9.2 Africa EPA/DHA (Omega 3) Ingredients Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania EPA/DHA (Omega 3) Ingredients Sales Volume (2015-2020)
3.10.1 Oceania EPA/DHA (Omega 3) Ingredients Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania EPA/DHA (Omega 3) Ingredients Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America EPA/DHA (Omega 3) Ingredients Sales Volume (2015-2020)
3.11.1 South America EPA/DHA (Omega 3) Ingredients Sales Volume Growth Rate (2015-2020)
3.11.2 South America EPA/DHA (Omega 3) Ingredients Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World EPA/DHA (Omega 3) Ingredients Sales Volume (2015-2020)
3.12.1 Rest of the World EPA/DHA (Omega 3) Ingredients Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World EPA/DHA (Omega 3) Ingredients Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America EPA/DHA (Omega 3) Ingredients Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia EPA/DHA (Omega 3) Ingredients Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe EPA/DHA (Omega 3) Ingredients Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia EPA/DHA (Omega 3) Ingredients Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia EPA/DHA (Omega 3) Ingredients Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East EPA/DHA (Omega 3) Ingredients Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa EPA/DHA (Omega 3) Ingredients Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania EPA/DHA (Omega 3) Ingredients Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America EPA/DHA (Omega 3) Ingredients Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World EPA/DHA (Omega 3) Ingredients Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global EPA/DHA (Omega 3) Ingredients Sales Volume Market Share by Type (2015-2020)
14.2 Global EPA/DHA (Omega 3) Ingredients Sales Revenue Market Share by Type (2015-2020)
14.3 Global EPA/DHA (Omega 3) Ingredients Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global EPA/DHA (Omega 3) Ingredients Consumption Volume by Application (2015-2020)
15.2 Global EPA/DHA (Omega 3) Ingredients Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in EPA/DHA (Omega 3) Ingredients Business
16.1 Omega Protein
16.1.1 Omega Protein Company Profile
16.1.2 Omega Protein EPA/DHA (Omega 3) Ingredients Product Specification
16.1.3 Omega Protein EPA/DHA (Omega 3) Ingredients Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Lonza
16.2.1 Lonza Company Profile
16.2.2 Lonza EPA/DHA (Omega 3) Ingredients Product Specification
16.2.3 Lonza EPA/DHA (Omega 3) Ingredients Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Axellus
16.3.1 Axellus Company Profile
16.3.2 Axellus EPA/DHA (Omega 3) Ingredients Product Specification
16.3.3 Axellus EPA/DHA (Omega 3) Ingredients Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 DSM
16.4.1 DSM Company Profile
16.4.2 DSM EPA/DHA (Omega 3) Ingredients Product Specification
16.4.3 DSM EPA/DHA (Omega 3) Ingredients Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 Algae EPAX
16.5.1 Algae EPAX Company Profile
16.5.2 Algae EPAX EPA/DHA (Omega 3) Ingredients Product Specification
16.5.3 Algae EPAX EPA/DHA (Omega 3) Ingredients Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 BASF
16.6.1 BASF Company Profile
16.6.2 BASF EPA/DHA (Omega 3) Ingredients Product Specification
16.6.3 BASF EPA/DHA (Omega 3) Ingredients Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 Croda
16.7.1 Croda Company Profile
16.7.2 Croda EPA/DHA (Omega 3) Ingredients Product Specification
16.7.3 Croda EPA/DHA (Omega 3) Ingredients Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 Aker BioMarine
16.8.1 Aker BioMarine Company Profile
16.8.2 Aker BioMarine EPA/DHA (Omega 3) Ingredients Product Specification
16.8.3 Aker BioMarine EPA/DHA (Omega 3) Ingredients Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 Martek
16.9.1 Martek Company Profile
16.9.2 Martek EPA/DHA (Omega 3) Ingredients Product Specification
16.9.3 Martek EPA/DHA (Omega 3) Ingredients Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.10 GC Rieber Oils
16.10.1 GC Rieber Oils Company Profile
16.10.2 GC Rieber Oils EPA/DHA (Omega 3) Ingredients Product Specification
16.10.3 GC Rieber Oils EPA/DHA (Omega 3) Ingredients Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 EPA/DHA (Omega 3) Ingredients Manufacturing Cost Analysis
17.1 EPA/DHA (Omega 3) Ingredients Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of EPA/DHA (Omega 3) Ingredients
17.4 EPA/DHA (Omega 3) Ingredients Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 EPA/DHA (Omega 3) Ingredients Distributors List
18.3 EPA/DHA (Omega 3) Ingredients Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of EPA/DHA (Omega 3) Ingredients (2021-2026)
20.2 Global Forecasted Revenue of EPA/DHA (Omega 3) Ingredients (2021-2026)
20.3 Global Forecasted Price of EPA/DHA (Omega 3) Ingredients (2015-2026)
20.4 Global Forecasted Production of EPA/DHA (Omega 3) Ingredients by Region (2021-2026)
20.4.1 North America EPA/DHA (Omega 3) Ingredients Production, Revenue Forecast (2021-2026)
20.4.2 East Asia EPA/DHA (Omega 3) Ingredients Production, Revenue Forecast (2021-2026)
20.4.3 Europe EPA/DHA (Omega 3) Ingredients Production, Revenue Forecast (2021-2026)
20.4.4 South Asia EPA/DHA (Omega 3) Ingredients Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia EPA/DHA (Omega 3) Ingredients Production, Revenue Forecast (2021-2026)
20.4.6 Middle East EPA/DHA (Omega 3) Ingredients Production, Revenue Forecast (2021-2026)
20.4.7 Africa EPA/DHA (Omega 3) Ingredients Production, Revenue Forecast (2021-2026)
20.4.8 Oceania EPA/DHA (Omega 3) Ingredients Production, Revenue Forecast (2021-2026)
20.4.9 South America EPA/DHA (Omega 3) Ingredients Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World EPA/DHA (Omega 3) Ingredients Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of EPA/DHA (Omega 3) Ingredients by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of EPA/DHA (Omega 3) Ingredients by Country
21.2 East Asia Market Forecasted Consumption of EPA/DHA (Omega 3) Ingredients by Country
21.3 Europe Market Forecasted Consumption of EPA/DHA (Omega 3) Ingredients by Countriy
21.4 South Asia Forecasted Consumption of EPA/DHA (Omega 3) Ingredients by Country
21.5 Southeast Asia Forecasted Consumption of EPA/DHA (Omega 3) Ingredients by Country
21.6 Middle East Forecasted Consumption of EPA/DHA (Omega 3) Ingredients by Country
21.7 Africa Forecasted Consumption of EPA/DHA (Omega 3) Ingredients by Country
21.8 Oceania Forecasted Consumption of EPA/DHA (Omega 3) Ingredients by Country
21.9 South America Forecasted Consumption of EPA/DHA (Omega 3) Ingredients by Country
21.10 Rest of the world Forecasted Consumption of EPA/DHA (Omega 3) Ingredients by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer